Cargando…

Interaction effect between fasting plasma glucose and lipid profiles on mortality of peritoneal dialysis patients

BACKGROUND: Peritoneal dialysis (PD) patients have a high risk of abnormal glucose and lipids metabolism. OBJECTIVE: We investigated the effects of baseline fasting plasma glucose (FPG) as well as its interaction with lipid profiles on all-cause and cardiovascular disease (CVD) cause-specific mortal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yiping, Zhong, Zhong, Li, Yi, Li, Zhijian, Zhou, Yi, Li, Zhibin, Mao, Haiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061421/ https://www.ncbi.nlm.nih.gov/pubmed/37007694 http://dx.doi.org/10.1093/ckj/sfac266

Ejemplares similares

Effect of Mean Platelet Volume to Platelet Count Ratio on Mortality in Peritoneal Dialysis
por: Chen, Jiasi, et al.
Publicado: (2022)

Serum Hepcidin-25 and Risk of Mortality in Patients on Peritoneal Dialysis
por: Zhong, Zhong, et al.
Publicado: (2021)

The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients
por: Ye, Hongjian, et al.
Publicado: (2017)

Serum Phosphorus and Albumin in Patients Undergoing Peritoneal Dialysis: Interaction and Association With Mortality
por: Huang, Naya, et al.
Publicado: (2021)

Systemic Immune-Inflammation Index Was Significantly Associated with All-Cause and Cardiovascular-Specific Mortalities in Patients Receiving Peritoneal Dialysis
por: Li, Guanglan, et al.
Publicado: (2023)

Plasma fibrinogen and mortality in patients undergoing peritoneal dialysis: a prospective cohort study
por: Yu, Jing, et al.
Publicado: (2020)

High Peritoneal Transport Status Was Not Associated with Mortality in Peritoneal Dialysis Patients with Diabetes
por: Huang, Naya, et al.
Publicado: (2014)

The Potential Role of HMGB1 Release in Peritoneal Dialysis-Related Peritonitis
por: Cao, Shirong, et al.
Publicado: (2013)

Therapeutic mechanism of baicalein in peritoneal dialysis-associated peritoneal fibrosis based on network pharmacology and experimental validation
por: Lu, Xiaohui, et al.
Publicado: (2023)

Serum Potassium Levels and Its Variability in Incident Peritoneal Dialysis Patients: Associations with Mortality
por: Xu, Qingdong, et al.
Publicado: (2014)

Association of Body Mass Index and Body Mass Index Change with Mortality in Incident Peritoneal Dialysis Patients
por: Xiong, Liping, et al.
Publicado: (2015)

The centre-calculated cutoff value is better for identifying fast peritoneal solute transfer of patients on peritoneal dialysis than the traditional value: a retrospective cohort study
por: Guo, Jing, et al.
Publicado: (2023)

Predicting One-Year Mortality in Peritoneal Dialysis Patients: An Analysis of the China Peritoneal Dialysis Registry
por: Cao, Xue-Ying, et al.
Publicado: (2015)

Factors Influencing the Choice of Automated Peritoneal Dialysis Treatment by Patients Receiving Home Peritoneal Dialysis
por: Cao, Fang, et al.
Publicado: (2023)

Construction and validation of a predictive model for the risk of peritoneal dialysis-associated peritonitis after peritoneal dialysis catheterization
por: Dai, Rong, et al.
Publicado: (2023)

Urgent-start peritoneal dialysis for patients with end stage renal disease: a 10-year retrospective study
por: Ye, Hongjian, et al.
Publicado: (2019)

Roles of peritoneal clearance and residual kidney removal in control of uric acid in patients on peritoneal dialysis
por: Xiao, Xi, et al.
Publicado: (2020)

Incidence and mortality of new-onset glucose disorders in peritoneal dialysis patients in China: a meta-analysis
por: Shi, Yanan, et al.
Publicado: (2020)

Creatine Kinase and Mortality in Peritoneal Dialysis
por: Wu, Xianfeng, et al.
Publicado: (2022)

Hyperlipidemia and mortality in patients on peritoneal dialysis
por: Feng, Xiaoran, et al.
Publicado: (2022)

Apolipoprotein A-I attenuates peritoneal fibrosis associated with peritoneal dialysis by inhibiting oxidative stress and inflammation
por: Lu, Jing, et al.
Publicado: (2023)

Association of baseline, longitudinal serum high-sensitive C-reactive protein and its change with mortality in peritoneal dialysis patients
por: Li, Wei, et al.
Publicado: (2017)

Association of inflammatory cytokines with mortality in peritoneal dialysis patients
por: Liu, Yao-Lung, et al.
Publicado: (2017)

Peritoneal Protein Clearance Is Associated With Cardiovascular Events but Not Mortality in Peritoneal Dialysis Patients
por: Niu, Wei, et al.
Publicado: (2022)

The predictive study of the relation between elevated low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and mortality in peritoneal dialysis
por: Lin, Tong, et al.
Publicado: (2020)

Elevated triglyceride-glucose index predisposes to the initial episode of peritonitis in chronic peritoneal dialysis patients
por: Liu, Guiling, et al.
Publicado: (2023)

Dialysis Duration and Glucose Exposure Amount Do Not Increase Mortality Risk in Peritoneal Dialysis Patients: A Population-Based Cohort Study From 2004 to 2012
por: Wu, Pei-Yu, et al.
Publicado: (2022)

Triglyceride glucose-body mass index and cardiovascular mortality in patients undergoing peritoneal dialysis: a retrospective cohort study
por: Zhan, Cuixia, et al.
Publicado: (2023)

Cytotoxic Glucose Degradation Products in Fluids for Peritoneal Dialysis
por: Adib, Noushin, et al.
Publicado: (2011)

Novel Method for Osmotic Conductance to Glucose in Peritoneal Dialysis
por: Martus, Giedre, et al.
Publicado: (2020)

Skin Autofluorescence and Mortality in Patients on Peritoneal Dialysis
por: Mácsai, Emília, et al.
Publicado: (2015)

Gene polymorphisms of VEGF and KDR are associated with initial fast peritoneal solute transfer rate in peritoneal dialysis
por: Qian, Yue, et al.
Publicado: (2022)

Plasma cholinesterase activity in patients during peritoneal dialysis
por: Popovic, L, et al.
Publicado: (2009)

Effect of glucose concentration on peritoneal inflammatory cytokines in continuous ambulatory peritoneal dialysis patients.
por: Sayarlioglu, Hayriye, et al.
Publicado: (2004)

Risk factors and outcomes of cardiovascular disease readmission within the first year after dialysis in peritoneal dialysis patients
por: Li, Jianbo, et al.
Publicado: (2021)

Impact of Environmental Particulate Matter and Peritoneal Dialysis-related Infection in Patients Undergoing Peritoneal Dialysis
por: Huang, Wen-Hung, et al.
Publicado: (2014)

The Role of Peritoneal Alternatively Activated Macrophages in the Process of Peritoneal Fibrosis Related to Peritoneal Dialysis
por: Wang, Jie, et al.
Publicado: (2013)

The Effect of Far-Infrared Therapy on the Peritoneal Expression of Glucose Degradation Products in Diabetic Patients on Peritoneal Dialysis
por: Chang, Chia-Ning, et al.
Publicado: (2021)

Impact of early-onset peritonitis on mortality and technique survival in peritoneal dialysis patients
por: Feng, Sheng, et al.
Publicado: (2016)

Hyponatremia as a Predictor of Mortality in Peritoneal Dialysis Patients
por: Chang, Tae Ik, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_on2168l92scvvl46jtdbk36cum